Betamethasone dipropionate

Lupin Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Nov 13, 2025
Approval ID: 216d5b7f-4236-4882-b899-be17cb1a1584
Products: 1 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use BETAMETHASONE DIPROPIONATE OINTMENT USP (AUGMENTED) safely and effectively. See full prescribing information for BETAMETHASONE DIPROPIONATE OINTMENT USP (AUGMENTED). BETAMETHASONE DIPROPIONATE ointment USP (Augmented), for topical useInitial U.S. Approval: 1983

Quick Stats

Total Products1

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.